All News
#ACR19 @rheumnow ABS 1237 OLT1177, oral NLRP3 inflammasome inhibitor- a potential drug for Rx of gout flares: ⬇️ systemic inflamm by ⬇️ WBC count & circulating IL-1β& IL-6 in all3 doses (2000mg, 1000mg or 300mg). ⬇️ ex vivo IL-1β & IL-6 production by cultured PBMCs days 3, 7& 14
Olga Petryna DrPetryna ( View Tweet)
#ACR19 @rheumnow abs1353 Observational SMART-RA trial concludes smart phone app based RA management improves DAS28 (p < 0.05), ESR (p≤0.05), CRP (p≤0.05) and HAQ-DI (p≤0.5) after 1y of use, suggesting smart phone technology improves quality of life & disease control in RA https://t.co/rERu2oF2VT
Olga Petryna DrPetryna ( View Tweet)
Abstr#1759: 64 pts randomized to either MTX 10mg or PBO. Evolution of pain b/w 2 groups no different. Function no different. Dose too low? PBO effect? Structural evolution modified by MTX. Is that our goal? #ACR19 @RheumNow #OA #osteoarthritis
Maeve Gamble MaeveGamble ( View Tweet)
#Rheumatology is the best field in medicine!
#RheumatologyMeme #ACR19 @ACRheum https://t.co/SmxjmTbV0j
Adam Kilian MD KilianMD ( View Tweet)
PATCH study: HCQ 400mg started by wk 10 gestation significantly reduces the recurrence of CHB below the historical rate of 18% to 7.4%. #ACR19 @RheumNow
Maeve Gamble MaeveGamble ( View Tweet)
IFX detected in stool a/w higher CRP and active bowel disease.
An inflamed bowel can change the pharmacodynamics of some of the therapies we use. Low albumin may indicate leaky gut. #ACR19 @RheumNow #IBD #AS #ankylosingspondylitis https://t.co/1BTU0guOC1
Maeve Gamble MaeveGamble ( View Tweet)
Choosing the right medication matters, but choosing the wrong medication also matters - Dr. Edward Behrens
#ACR19 @RheumNow
Kanika Monga, MD DrKanikaMonga ( View Tweet)
Higher risk patients – Antimalarial Retinal Toxicity
- Concomitant tamoxifen (increase risk 5-fold)
- GFR <50 cc/min
- Dose >5 mg/kg
#ACR19 @RheumNow
Kanika Monga, MD DrKanikaMonga ( View Tweet)
Urate lowering therapy indications for #Gout:
- Tophi
- Frequent flares ( ≥ 2/yr)
- Chronic kidney disease
- Hx of renal stones
Will these change in the 2019 guidelines?
#ACR19 @RheumNow
Kanika Monga, MD DrKanikaMonga ( View Tweet)
🤳My first ever selfie video series -- I ask the experts for some twitter advice! Come tag along with me :)
#ACR19 @RheumNow @ACRheum @UTHealth
Kanika Monga, MD DrKanikaMonga ( View Tweet)
Retrospective review of 236 RA pts and 166 pts w/other systemic diseases who received Shingrix: no significant increase risk in disease flare or vaccine-related AEs. Abstr#1804 #ACR19 #whyivaccinate @RheumNow @LCalabreseDO @BetsyKirch
Cassandra Calabrese CCalabreseDO ( View Tweet)
Abstr#1802 - nice study from @CleClinicMD confirming low clinical value of annual quantiferon screening for LTBI in the absence of new or ongoing risk factor #ACR2019 @RheumNow @ElaineHusniMD #cleclinicrheum
Cassandra Calabrese CCalabreseDO ( View Tweet)
Abstr#1806: Another centre’s experience with IA-irAEs from ICIs #ACR19 @RheumNow https://t.co/OFZaYqMSFR
Maeve Gamble MaeveGamble ( View Tweet)
Don’t forget to check immunoglobulins prior to starting Rituximab! Thanks for sharing our results! @hausmannMD #ACR19 @RheumNow https://t.co/PNGe72waez
Stefanie D Wade, MD doctorswade ( View Tweet)
Beware hydralazine! Associated vasculitis with high frequency of CKD and poor outcomes. 100%renal involvement and ANCA positivity! Abstr#1667 @SajaAlmaaitah @kinanah9 @CleClinicMD #cleclinicrheum #ACR19 @RheumNow https://t.co/qJM49xN6Rx
Cassandra Calabrese CCalabreseDO ( View Tweet)
Abstr#824 VERVE results - safety of live heroes zoster vaccine in pts on TNFi- no cases of vaccine-related varicella @LCalabreseDO @BetsyKirch @RheumNow #ACR19 #cleclinicrheum https://t.co/zPDvQujgzP
Cassandra Calabrese CCalabreseDO ( View Tweet)
Excellent irAE summary by Ryan Sullivan -judicious use of steroids, High doses when needed, low dose when possible. Pre-existing AID not a contradiction to checkpoint inhibitor Tx! @RheumNow @LCalabreseDO @cappelliMD @lexmeara #ACR19 #cleclinicrheum https://t.co/TOTXQzxXhp
Cassandra Calabrese CCalabreseDO ( View Tweet)
Do you co-manage your PsO/PsA patients with dermatology? #ACR19 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
So glad that our clinical study from @RBNHSFT looking at the outcome measures in Axial Spondyloarthritis eg. BASDAI, ASDAS, CRP, BASFI and the impact on response to treatment was delivered today as an oral presentation with good feedback at #ACR19 #axialspondyloarthritis
Dr. Antoni Chan synovialjoints ( View Tweet)
Continued Ixekizumab was superior to PBO in maintaining MDA in biologic-naïve PsA pts who achieved sustained MDA on initial IXE treatment. A vast majority of pts who lost MDA after IXE withdrawal regained MDA with IXE re-treatment presented by @DrLauraCoates #ACR19 @RheumNow
Dr. Antoni Chan synovialjoints ( View Tweet)